[New substances need critical appraisal, unequivocal information and time. COX-2-inhibitors between cold facts and media hype].
Stichtenoth
Dirk O
DO
Komm. Leiter des Instituts für Klinische Pharmakologie Medizinische Hochschule Hannover.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D016861:Cyclooxygenase Inhibitors